Your browser doesn't support javascript.
loading
CYP3A4*22 may increase bleeding risk in ticagrelor users.
Liedes, Hilkka; Pajula, Juha; Vuorinen, Anna-Leena; De Pretis, Francesco; van Gils, Mark; Harno, Kari; Lehto, Mika; Niemi, Mikko; Lähteenmäki, Jaakko.
Affiliation
  • Liedes H; VTT Technical Research Centre of Finland Ltd., Oulu, Finland.
  • Pajula J; VTT Technical Research Centre of Finland Ltd., Tampere, Finland.
  • Vuorinen AL; VTT Technical Research Centre of Finland Ltd., Tampere, Finland.
  • De Pretis F; VTT Technical Research Centre of Finland Ltd., Kuopio, Finland.
  • van Gils M; VTT Technical Research Centre of Finland Ltd., Tampere, Finland.
  • Harno K; Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland.
  • Lehto M; Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
  • Niemi M; Faculty of Medicine, Clinicum, University of Helsinki, Helsinki, Finland.
  • Lähteenmäki J; Department of Clinical Pharmacology and Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
Basic Clin Pharmacol Toxicol ; 133(2): 202-207, 2023 08.
Article in En | MEDLINE | ID: mdl-37162098

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Coronary Syndrome / Percutaneous Coronary Intervention Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Basic Clin Pharmacol Toxicol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acute Coronary Syndrome / Percutaneous Coronary Intervention Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Basic Clin Pharmacol Toxicol Journal subject: FARMACOLOGIA / TOXICOLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: